<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0"><channel><title>Individual feed for https://www.medscape.com/cx/rssfeeds/2700.xml</title><link>https://www.medscape.com/cx/rssfeeds/2700.xml</link><description>Individual feed output.</description><lastBuildDate>Wed, 10 Sep 2025 11:14:44 GMT</lastBuildDate><generator>PyRSS2Gen-1.1.0</generator><docs>http://blogs.law.harvard.edu/tech/rss</docs><item><title>Polyomavirus Antibody Test Predicts Merkel Cell Recurrence</title><link>https://www.medscape.com/viewarticle/polyomavirus-antibody-test-predicts-merkel-cell-carcinoma-2025a1000nv3?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture1.png</image_url><description>Rising Merkel cell polyomavirus oncoprotein antibody titers predict a 58% recurrence risk at 12 months, while falling or negative titers are associate...</description><pubDate>Wed, 10 Sep 2025 16:05:00 GMT</pubDate></item><item><title>Is Contrast-Free MRI the Optimal Test for PC?</title><link>https://www.medscape.com/viewarticle/contrast-free-mri-optimal-test-pc-2025a1000nv9?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture7.png</image_url><description>A new study finds biparametric MRI fared no worse than standard imaging at identifying prostate cancers, while avoiding risks from contrast injections...</description><pubDate>Wed, 10 Sep 2025 16:05:00 GMT</pubDate></item><item><title>Do Autoantibody Profiles Vary in Dermatomyositis Subtypes?</title><link>https://www.medscape.com/viewarticle/do-autoantibody-profiles-vary-dermatomyositis-subtypes-2025a1000nvo?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture8.png</image_url><description>Commercial autoantibody testing shows similar positivity rates for myositis-specific autoantibodies and myositis-associated autoantibodies between dif...</description><pubDate>Wed, 10 Sep 2025 16:05:00 GMT</pubDate></item><item><title>How Doctors Manage Rising Patient Autonomy and Anxiety</title><link>https://www.medscape.com/viewarticle/how-doctors-manage-rising-patient-autonomy-and-anxiety-age-2025a1000ny1?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture10.png</image_url><description>As patients learn more medical information online and bring rising anxiety into the exam room, doctors must adapt their approach to inform and empower...</description><pubDate>Wed, 10 Sep 2025 15:39:02 GMT</pubDate></item><item><title>Concurrent Durvalumab Shows No Survival Benefit in NSCLC</title><link>https://www.medscape.com/viewarticle/concurrent-durvalumab-shows-no-survival-benefit-nsclc-2025a1000nxs?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture6.png</image_url><description>Phase 3 trial finds adding durvalumab during chemoradiation does not improve overall survival compared with standard consolidation therapy alone. Meds...</description><pubDate>Wed, 10 Sep 2025 15:17:46 GMT</pubDate></item></channel></rss>